Literature DB >> 19085222

Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria.

Malini B DeSilva1, Stephen P Merry, Philip R Fischer, James E Rohrer, Christian O Isichei, Stephen S Cha.   

Abstract

This retrospective study identifies risk factors for mortality in a cohort of HIV-positive adult patients treated with highly active antiretroviral therapy (HAART) in Jos, Nigeria. We analyzed clinical data from a cohort of 1552 patients enrolled in a HIV/acquired immune deficiency syndrome treatment program and started on HAART between December 2004 and 30 April 2006. Death was our study endpoint. Patients were followed in the study until death, being lost to follow-up, or the end of data collection, 1 December 2006. Baseline patient characteristics were compared using Wilcoxon Rank Sum Test for continuous variables and Pearson Chi-Square test for categorical variables to determine if certain demographic factors were associated with more rapid progression to death. The Cox proportional hazard multivariate model analysis was used to find risk factors. As of 1 December 2006, a total of 104 cases progressed to death. In addition to the expected association of CD4 count less than 50 at initiation of therapy and active tuberculosis with mortality, the patient characteristics independently associated with a more rapid progression to death after initiation of HAART were male gender, age less than 30 years old, and unemployment or unknown occupation status. Future research is needed to identify the confounding variables that may be amenable to targeted interventions aimed at ameliorating these health disparities.

Entities:  

Mesh:

Year:  2009        PMID: 19085222      PMCID: PMC2849645          DOI: 10.1080/09540120802017636

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  31 in total

1.  Lack of sex difference in CD4 to HIV-1 RNA viral load ratio.

Authors:  R D Moore; L Cheever; J C Keruly; R E Chaisson
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

2.  AIDS mortality in a tertiary health institution: A four-year review.

Authors:  Mahmoud U Sani; Aminu Z Mohammed; Bappa Adamu; Shehu M Yusuf; Adamu A Samaila; Musa M Borodo
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

3.  HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.

Authors:  Chris Duncombe; Stephen J Kerr; Kiat Ruxrungtham; Gregory J Dore; Matthew G Law; Sean Emery; Joep M Lange; Praphan Phanuphak; David A Cooper
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

4.  Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy.

Authors:  Emanuele Nicastri; Claudio Angeletti; Lucia Palmisano; Loredana Sarmati; Antonio Chiesi; Andrea Geraci; Massimo Andreoni; Stefano Vella
Journal:  AIDS       Date:  2005-03-24       Impact factor: 4.177

5.  Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons.

Authors:  Angel M Mayor; María A Gómez; Eddy Ríos-Oliveras; Robert F Hunter-Mellado
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

6.  From mandatory to voluntary testing: balancing human rights, religious and cultural values, and HIV/AIDS prevention in Ghana.

Authors:  Isaac N Luginaah; Emmanuel K Yiridoe; Mary-Margaret Taabazuing
Journal:  Soc Sci Med       Date:  2005-10       Impact factor: 4.634

7.  Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.

Authors:  Stephen R Cole; Miguel A Hernán; Joseph B Margolick; Mardge H Cohen; James M Robins
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

Review 8.  Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries.

Authors:  J T Boerma; A J Nunn; J A Whitworth
Journal:  AIDS       Date:  1998       Impact factor: 4.177

9.  The mortality and pathology of HIV infection in a west African city.

Authors:  S B Lucas; A Hounnou; C Peacock; A Beaumel; G Djomand; J M N'Gbichi; K Yeboue; M Hondé; M Diomande; C Giordano
Journal:  AIDS       Date:  1993-12       Impact factor: 4.177

10.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

View more
  24 in total

1.  Gender inequality: Bad for men's health.

Authors:  M Cornell
Journal:  South Afr J HIV Med       Date:  2013-01-01       Impact factor: 2.744

2.  Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.

Authors:  John Idoko; Seema Meloni; Mohammed Muazu; Ladep Nimzing; Bitrus Badung; Claudia Hawkins; Jean-Louis Sankalé; Ernest Ekong; Robert Murphy; Phyllis Kanki; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

3.  Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria.

Authors:  Baba M Musa; Musa A Garbati; Ibrahim M Nashabaru; Shehu M Yusuf; Aisha M Nalado; Daiyabu A Ibrahim; Melynda N Simmons; Muktar H Aliyu
Journal:  Int Health       Date:  2016-12-09       Impact factor: 2.473

Review 4.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

5.  Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda.

Authors:  Arif Alibhai; Walter Kipp; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Stan Houston; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale
Journal:  Int J Womens Health       Date:  2010-08-09

6.  Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.

Authors:  Anna Thora Grimsrud; Morna Cornell; Matthias Egger; Andrew Boulle; Landon Myer
Journal:  J Clin Epidemiol       Date:  2013-06-15       Impact factor: 6.437

7.  The role of host gender in the pathogenesis of Cryptococcus neoformans infections.

Authors:  Erin E McClelland; Letizia M Hobbs; Johanna Rivera; Arturo Casadevall; Wayne K Potts; Jennifer M Smith; Jeramia J Ory
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 8.  Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Steven Y Hong; Silvia Bertagnolio; Michael R Jordan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

9.  Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria.

Authors:  Dimie Ogoina; Reginald O Obiako; Haruna M Muktar; Mukhtar Adeiza; Aliyu Babadoko; Abdulaziz Hassan; Isa Bansi; Henry Iheonye; Matthew Iyanda; Eric Tabi-Ajayi
Journal:  AIDS Res Treat       Date:  2012-09-17

10.  Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.

Authors:  Mathieu Bastard; Khamphang Soulinphumy; Prasith Phimmasone; Ahmed Hassani Saadani; Laura Ciaffi; Arlette Communier; Chansy Phimphachanh; René Ecochard; Jean-François Etard
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.